V.4 Toremifene and the uterus

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Tomas E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TAMOXIFEN; TOREMIFENE;

BREAST CANCER; CONFERENCE PAPER; CYTOLOGY; DRUG EFFICACY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; HUMAN; HYSTEROSCOPY; NONHUMAN; PAPANICOLAOU TEST; POLYP; PRIORITY JOURNAL; THICKNESS; TRANSVAGINAL ECHOGRAPHY; UTERUS;

EID: 0031710798     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00118-X     Document Type: Conference Paper

References (4)

1. Kallio S, Kangas L, Blanco G, et al. A new triphenylethylene compound, Fc-1157a. I. Hormonal effects. Cancer Chemother Pharmacol 1986, 17, 103-108.
2. Kangas L, Nieminen A-L, Blanco G, et al. A new triphenylethylene compound, Fe-1157a. II. Antitumor effects. Cancer Chemother Pharmacol 1986, 17, 109-113.
3. di Salle E, Zaccheo T, Ornati G. Antiestrogenic and antitumor properties of the new triphenylethylene derivate toremifene in the rat. J Steroid Biochem 1990, 36, 203-206.
4. Tomás E, Kauppila A, Blanco G, et al. Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients. Gynecol Oncol 1995, 59, 261-266.